CIRS Group Shines at KIMES 2026 in South Korea, Concludes Thematic Seminar with Success

From March 19 to 22, 2026, the Korea International Medical & Hospital Equipment Show (KIMES) was successfully held at COEX Convention & Exhibition Center in Seoul, Korea. The medical device technical team of CIRS Group was invited to attend the event, and jointly held a special seminar on FDA & CE MDR Certification and NMPA Clinical Evaluation with the organizer. Empowering Chinese, Korean and global medical device enterprises to comply with regulations and expand overseas with professional regulatory services, CIRS Group has gained high attention and wide recognition from the industry.

As an authoritative Asian medical industry exhibition certified by the Global Association of the Exhibition Industry (UFI), KIMES 2026 gathered more than 1,400 participating brands worldwide and attracted over 70,000 professional visitors. Focusing on cutting-edge technologies and trade cooperation in medical devices, hospital equipment, healthcare supplies and other fields, it has become an important platform for the Asian medical industry to connect with the global market.

During the exhibition, the special seminar hosted by CIRS Group Korea was successfully held on March 19 at Room 402, 4th Floor, COEX Conference Rooms. Cindy Fu and Edwin Wen, senior regulatory experts of CIRS Group, delivered in-depth presentations on core topics respectively, accurately analyzing the difficulties in global certification of medical devices and key points of clinical evaluation:

· Systematically interpreting the certification requirements, process changes and practical points of medical devices in the three core markets of FDA, CE MDR and NMPA, providing a clear compliance path for enterprises’ global layout;

· Focusing on the latest policies, review points and case practices of China’s medical device clinical evaluation, helping enterprises efficiently complete domestic clinical evaluation and registration applications.

The seminar was fully attended, with enterprise representatives actively raising questions, and the expert team providing detailed answers to compliance concerns. After the seminar, the technical team of CIRS Group conducted in-depth one-on-one exchanges with many Korean medical device enterprises and industry institutions, providing customized regulatory solutions for certification applications, clinical evaluation, market access and other needs, building an efficient bridge for medical compliance between China and Korea, and winning unanimous praise from the participants.

CIRS Group’s appearance at KIMES 2026 not only demonstrated its professional strength and industry influence in the field of global regulatory services for medical devices, but also further deepened cooperation and connections with the Asian medical industry. In the future, CIRS Group will continue to focus on the medical device compliance sector, keep pace with the latest trends in global regulations, and assist more medical device enterprises in breaking through compliance barriers and smoothly exploring domestic and international markets with more professional and comprehensive technical services, so as to promote the compliant and efficient development of the global medical industry.